Corrigendum: Open House Original Discount Agreements 2023-16 - Bimatoprost Timolol (Dosage Form: Eye Drops as Single-Dose Pipettes) The health insurance companies involved pursue the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a (8) SGB V for the active ingredient bimatoprost timolol (dosage form: eye drops as single-dose pipettes). The contract is concluded as part of the Open House Originalinale procedure of the health insurance companies: Individual negotiations about contract contents are not carried out; uniform conditions apply. The health insurance companies do not guarantee individual contractual partners exclusivity. The contract term is a maximum of 24 months starting on July 1st, 2023. The VIncome ends on June 30, 2025 at the latest, regardless of the date the contract was concluded. If the patent expires before the above-mentioned end date, the contract ends automatically at the end of the month in which the patent expires. All further information can be found in the participation and contract documents. Doc Title: Pharmaceutical products Contract Type: Supplies TECHNICIANS' HEALTH INSURANCE Address : Bramfelder Str. 140 Town : Hamburg NUTS-Code : DE300 - Berlin Postal Code : 22305 Contact Point : DZ EM, Ü32.02.10 dzem@tk.de Tender Notice International Competitive Bidding 789723-2023 Germany GT-94352783

Germany